INTERNATIONAL PATENT: SUN PHARMACEUTICAL INDUSTRIES LIMITED FILES APPLICATION FOR "LONG TERM SAFETY OF TILDRAKIZUMAB IN PSORIATIC ARTHRITIS"

GENEVA, April 6 -- SUN PHARMACEUTICAL INDUSTRIES LIMITED (Sun HousePlot No. 201 B/1Western Express Highway, Goregoan (E)Mumbai 400063) filed a patent application (PCT/IB2025/059796) for "LONG TERM SAFETY OF TILDRAKIZUMAB IN PSORIATIC ARTHRITIS" on Sep 29, 2025. With publication no. WO/2026/069253, the details related to the patent application was published on Apr 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HONCZARENKO, Marek (807 Bronson LaneHighland Park, Illinois 60036), SOULE, Benjamin P. (4 Hidden Hollow DriveHamilton, New Jersey 08620), MEHTA, Shantanu (1301, Anmol Pride, Govind...